The part about.....
"With no issues, objections or concerns to existing data raised and studies for the data requested now underway, these should be completed and ready for submission in the next several quarters."
Probably will not help the SP in the immediate future.
##################################################
However the other part about............
"Recce expects a substantial R&D rebate next month as already set aside as part of the Company’s Advanced Finding with the Australian Government, thus speeding the return of funds."
Might help to put a floor under the price.
Ann: Update on meeting with US FDA, page-7
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.015(3.30%) |
Mkt cap ! $104.2M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.0¢ | 45.5¢ | $64.42K | 139.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71081 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 28300 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |